PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-11-09 (14)

Date Title Company
09-Nov-2023 Atara Biotherapeutics Announces Primary Analysis Data from Phase 2 EMBOLD Clinical Trial of ATA188 in Non-Active Progressive Multiple Sclerosis Businesswire